169362 ⎘
Investigating or analysing materials by specific methods not covered by groups -; Biological material, e.g. blood, urine ; Haemocytometers; Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving narcotics or drugs or pharmaceuticals, neurotransmitters or associated receptors Antidepressants
METHOD FOR SIMULTANEOUS AND EFFICIENT DETECTION OF RESIDUES OF 36 ANTIDEPRESSANTS IN SLUDGES
#2GPCR SCREENING METHOD TO IDENTIFY NON-HALLUCINOGENIC COMPOUNDS
#3ANTIBODIES TO QUETIAPINE HAPTENS AND USE THEREOF
#4ANTIBODIES TO QUETIAPINE HAPTENS AND USE THEREOF
#5Antibodies to quetiapine and use thereof
#6ANTIBODIES TO QUETIAPINE AND USE THEREOF
#7Rapid and sensitive method of forensic toxicology in post-mortem subjects and in live and post-mortem animals using oral fluid testing
#8Antibodies to quetiapine haptens and use thereof
#9Antibodies to quetiapine and use thereof
#10Antibodies to quetiapine and use thereof
#11MULTIDRUG ANALYSIS IN URINE BY LIQUID CHROMATOGRAPHY-TANDEM MASS SPECTROMETRY
#12Blood biomarkers for suicidality
#13Method for Screening Lyophilized Parenteral Formulations
#14Methods for determining ligand binding to a target protein using a thermal shift assay
#15Venlafaxine assay
#16Methods for determining ligand binding to a target protein using a thermal shift assay
#17Antibodies to quetiapine and use thereof
#18Antibodies to quetiapine haptens and use thereof
#19MCPP immunoassay
#20Method for identifying antipsychotic drug candidates
#21Methods for assaying for antidepressant therapy markers
#22Immunoassays for everolimus
#23Immunoassays for everolimus
#24Marker for antidepressant therapy and methods related thereto